Examination of the Pancreas in New-onset Diabetes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

79 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-05-31

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer

NCT06299800

Diabetes Mellitus, Type 2 Cancer

RECRUITING

Screening and Intervention for Subclinical Coronary Artery Disease in Patients With Type 2 Diabetes

NCT05700877

Type 2 Diabetes Cardiovascular Diseases

RECRUITING PHASE4

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

NCT00520962

Diabetes Mellitus, Type 2

COMPLETED

Risk Evaluation of cAncers in Chinese diabeTic Individuals: a lONgitudinal Study

NCT01506869

Cancer

UNKNOWN

Morphological Pancreatic Features in Diabetes Mellitus Type 2

NCT05762653

Diabetes Mellitus, Type 2

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Compared to the general population, subjects \>50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

medical chart review

baseline, quarterly follow-up for 24 months

Intervention Type OTHER

survey administration

baseline

Intervention Type OTHER

Specimen collection

baseline

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patient Characteristics:

--Suspected or definite new-onset diabetes based on recent blood sugar and hemoglobin A1c values

* No acute illness or steroid therapy
* No prior pancreas surgery

Minimum Eligible Age

50 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No